Evidence map›Paper›PMID 40766962›Full record

ArticleFrontiers in behavioral neuroscience2025

Multi-domain destructuring in the early phases of psychosis: a multicentric phenomenological and psychometric case-control study.

Ottone Baccaredda Boy, Giuseppe Pierpaolo Merola, Andrea Patti, Bernardo Bozza, Dario Flaccomio, Marco Faldi, Giulia Pitt, Luca Papini, Vincenzo Pecoraro, Ilaria Noschese and 13 more

Abstract read
In one paragraph

Article in Frontiers in behavioral neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Ottone Baccaredda BoyAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Giuseppe Pierpaolo MerolaAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Andrea PattiEating Disorder Clinic "Residenza Gruber", Bologna, Italy.
Bernardo BozzaAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Dario FlaccomioAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Marco FaldiAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Giulia PittAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Luca PapiniAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Vincenzo PecoraroAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Ilaria NoscheseAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Elisa Di MatteoAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Dario BrugnoloAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Camilla RicciAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Andrea BalleriniAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Francesco MauceriAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Simone TavanoAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Giulio PeroniAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Sara CiabattiniAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
Sara GoriChild and Adolescent Psychiatric Unit, Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS, Florence, Italy.
Tiziana PisanoChild and Adolescent Psychiatric Unit, Neuroscience and Human Genetics Department, Meyer Children's Hospital IRCCS, Florence, Italy.
Francesco De CesarisAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.
David CohenChild and Adolescent Psychiatry Unit, Institute IDEAL, APHP, Sorbonne University, Hôpital Pitié-Salpêtrière, Paris, France.
Valdo RiccaAzienda Ospedaliera Universitaria Careggi Firenze, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The study aims to evaluate symptomatic differences through psychometric tools comparing patients in the early stages of psychotic development with those exhibiting a more established symptomatology. Our hypothesis was that the early phase in adolescent patients is accompanied by quantitatively and qualitatively distinct symptomatology compared to adults. Methods: We assessed 116 participants-consisting of 14 to 65 years old patients with psychotic or mood symptoms-using psychometric tools and a clinical interview. The tools explored psychotic, depressive and anxiety dimensions, to provide a multifaceted assessment of the recruited individuals and help at categorizing them into diagnostic subclasses. Results: We compared patients with psychotic symptoms (early-onset and lifetime) to patients with mood disorders (unipolar depression or bipolar disorder without psychotic symptoms). Psychotic symptoms intensity was significantly higher in the early-onset group compared to the lifetime group and was markedly greater than in the two other groups. It was also observed that the intensity of anxiety and depressive symptoms in the psychosis group were significantly higher in the early-onset subgroup. Conclusion: Our findings suggest that the clinical presentation of early-onset patients, typically striking in its symptomatology, is reflected by elevated scores on scales not routinely used for psychotic symptoms. This may be attributed to the pervasive destructuring of personality and reality characteristic of early psychotic experiences.

Indexed as

anxietycannabisdepressionFEPpsychosissalience

Identifiers

PMID40766962
PMCPMC12321885

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.